Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Alpert

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Journal of Psychiatric Research|March 16, 2013
Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory studyJohn J Mooney, Jacqueline A Samson, Nancy L McHale, et al.
Journal of Clinical Psychopharmacology|November 18, 2008
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disordersA Eden Evins, Melissa A Culhane, Jonathan E Alpert, et al.
International Journal of Psychiatry in Medicine|February 17, 2006
Outcomes of recognizing depressed Chinese American patients in primary careAlbert Yeung, Winnie W Kung, Jessica L Murakami, et al.
Psychosomatics|September 4, 2004
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatmentDan V Iosifescu, Andrew A Nierenberg, Jonathan E Alpert, et al.
Depression and Anxiety|September 10, 2003
Early-onset depression and the emotional and behavioral characteristics of offspringTimothy J Petersen, Jonathan E Alpert, George I Papakostas, et al.
International Clinical Psychopharmacology|August 16, 2003
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsedGeorge I Papakostas, Timothy Petersen, John J Worthington, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 20, 2004
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorderGeorge I Papakostas, Timothy Petersen, John W Denninger, et al.
The Journal of Clinical Psychiatry|January 2, 2007
A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatmentMaurizio Fava, Lesley M Graves, Franco Benazzi, et al.
Psychiatry Research|May 22, 2003
Somatic symptoms in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, John Denninger, et al.
The Journal of Nervous and Mental Disease|August 2, 2003
Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcomeGeorge I Papakostas, Timothy Petersen, Joel Pava, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Journal of Psychiatric Research|March 16, 2013
Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory studyJohn J Mooney, Jacqueline A Samson, Nancy L McHale, et al.
Journal of Clinical Psychopharmacology|November 18, 2008
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disordersA Eden Evins, Melissa A Culhane, Jonathan E Alpert, et al.
International Journal of Psychiatry in Medicine|February 17, 2006
Outcomes of recognizing depressed Chinese American patients in primary careAlbert Yeung, Winnie W Kung, Jessica L Murakami, et al.
Psychosomatics|September 4, 2004
Comorbid medical illness and relapse of major depressive disorder in the continuation phase of treatmentDan V Iosifescu, Andrew A Nierenberg, Jonathan E Alpert, et al.
Depression and Anxiety|September 10, 2003
Early-onset depression and the emotional and behavioral characteristics of offspringTimothy J Petersen, Jonathan E Alpert, George I Papakostas, et al.
International Clinical Psychopharmacology|August 16, 2003
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsedGeorge I Papakostas, Timothy Petersen, John J Worthington, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 20, 2004
Treatment-related adverse events and outcome in a clinical trial of fluoxetine for major depressive disorderGeorge I Papakostas, Timothy Petersen, John W Denninger, et al.
The Journal of Clinical Psychiatry|January 2, 2007
A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatmentMaurizio Fava, Lesley M Graves, Franco Benazzi, et al.
Psychiatry Research|May 22, 2003
Somatic symptoms in treatment-resistant depressionGeorge I Papakostas, Timothy Petersen, John Denninger, et al.
The Journal of Nervous and Mental Disease|August 2, 2003
Hopelessness and suicidal ideation in outpatients with treatment-resistant depression: prevalence and impact on treatment outcomeGeorge I Papakostas, Timothy Petersen, Joel Pava, et al.
Pageof 14